How did CTC.africa became a solution?
Africa accounts for approximately 18% of the global population and bears nearly 25% of the world’s disease burden. Despite this, the continent receives only 3–4% of global clinical research funding. This disparity limits Africa’s ability to contribute to and benefit from high-quality clinical research, slowing the development of locally relevant treatments and innovations.
The Clinical Trial Community (CTC) Platform was created to address this gap by showcasing Africa’s extensive research capabilities, improving access to information on clinical trial sites, regulatory pathways, and investigator expertise. By providing a centralised, transparent, and data-driven resource, the CTC platform aims to attract greater research investment, foster collaborations, and ultimately enhance Africa’s role in the global clinical research landscape.
Profile overview and account management
Effortless sign up on the go.
Users can use the CTC platform on their mobile phones to register new accounts, search entities via the interactive map, browse platform analytics, and access our support content.
Profiles
Help us keep the platform up to date
Profiles
Suggest updates to entity owners
Profiles
Request Capability Reports and updated centre information
Profiles
Sign up to stay up to date
Search for entities and trials with ease
Search
Search using our entity filters on map or list view
Entity Search
View entity profile pages
Our dedicated analytics page
Analytics
Study phase per year
Analytics
View data on study types per year and study phases per year
Our funding partners & data
Funding
R&D funding received per country
R&D funding reported to the G-FINDER survey
Funding
R&D funding received by African institutions, by funder
R&D funding reported to the G-FINDER survey
